Get access to everything we publish when you sign up for Outside+.
Scranton, PA; January 13, 2014 – Noble Biomaterials Inc., a global leader in bacterial management solutions and manufacturer of X-STATIC®, has hired Kelly Glowik as its Director of Business Development, Sports/Lifestyle. Glowik will be responsible for the business development of X-STATIC® Performance materials in the athletic, outdoor and lifestyle markets.
Glowik joins Noble from CoolCore, LLC., where she was Business Unit Manager responsible for international product development, design, and merchandising for Coolcore brand apparel and accessories, as well as the Dr. Cool brand, specializing in thermo-regulating textiles. Previously, she was Business Development Manager, Textiles and Consumer Goods, at Sciessent LLC., formerly Agion Technologies, Inc.
“Kelly is highly knowledgeable of performance textiles along with antibacterial solutions and their recommended use in specific applications,” said Guy Grubel, President Advanced Materials Division, Noble Biomaterials. “Additionally, she has business development experience in X-STATIC Performance’s key markets. We are happy to have Kelly on board!”
“X-STATIC® is without question the market leader in antibacterial, anti-odor technology,” said Glowik. “I look forward to working with world-class brands bringing innovative odor solutions to products made with X-STATIC®.”
Glowik, who reports to Grubel, holds a BA in Communications and Business Management from Emmanuel College and is based in Boston, MA.
Made with 99.9% pure silver, X-STATIC® enhances products with permanent anti-odor and antimicrobial performance. It naturally inhibits the growth of bacteria in apparel and textiles, keeping odors in check, gear smelling fresher and lasting longer. Proven by US Special Forces, NASA Astronauts and Olympic athletes, X-STATIC® delivers unmatched protection and performance. www.x-staticperformance.com.
About Noble Biomaterials
Headquartered in Scranton, PA, Noble Biomaterials, Inc. is a global leader in bacterial management solutions. The company develops, manufactures, sells and markets advanced antimicrobial technologies designed to manage all forms of bacterial contamination. It has more than 200 global licensees for products in the medical, defense, industrial and consumer markets. The company’s headquarters and manufacturing facilities are located in Scranton, PA, with offices in Europe, Asia and South America. www.noblebiomaterials.com
# # #